Dysregulation of MYB often associates with various hematological disorders including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic leukemia (ALL)3–5. This evidence concerns the gene MYB and acute myeloid leukemia.